Abstract
Four surgically aniridic vervet monkeys with clear lenses received topical echothiophate iodide unilaterally daily for eight weeks. The opposite eyes received a control solution without echothiophate. All the echothiophate-treated eyes developed subcapsular lens opacities sttongly resembling those attributed to echothiophate in humans. The lenses in the control eyes remained clear.